Search for Clinical Trial Results
Gout - 59 Studies Found
Status | Study |
Recruiting |
Study Name: The Clinical Study on Treating Acute Gouty Arthritis Using Both Internal and External Therapy of Tonifying Spleen and Descending Turbid Condition: Acute Gouty Arthritis Date: 2015-09-02 Interventions:
|
Completed |
Study Name: β-RELIEVED - REsponse in Acute fLare and In prEVEntion of episoDes of Re-flare in Gout - Extension 3 (E3) Condition: Acute Gouty Arthritis Flares Date: 2011-08-16 Interventions: Drug: ACZ885 canakinumab 150 mg s.c., given on demand upon new flares |
Completed |
Study Name: Safety & Efficacy of Canakinumab (ACZ885) in Patients With Frequent Flares for Whom Nonsterodial Anti-Inflammatory Drug (NSAIDs) and/ or Colchicine Are Contraindicated, Not Tolerated or Ineffective Condition: Gouty Arthritis Date: 2011-05-24 Interventions:
|
Withdrawn |
Study Name: Apremilast Therapy for Acute Gouty Arthritis Condition: Acute Gout Date: 2009-10-09 Interventions:
|
Completed |
Study Name: Efficacy and Safety of Lumiracoxib 400 mg Once Daily in Acute Flares of Gout Condition: Acute Gouty Arthritis Date: 2005-09-09 Interventions: Drug: Lumiracoxib |
Recruiting |
Study Name: Elastography as Gouty Arthropathy Outcome (EGO) Condition: Gout Date: 2015-06-11 |
Completed |
Study Name: AMPED Outcomes Registry of Post-ED Pain Management Condition:
|
Completed |
Study Name: Italian Observational Study Assessing the Impact of Gout on Patients Disability and Quality of Life Condition: Gout Date: 2012-03-06 |
Completed |
Study Name: Re-exposure Study of Pegloticase Intravenous (i.v.) in Symptomatic Gout Patients Condition: Chronic Gout Refractory to Conventional Therapy Date: 2008-05-06 Interventions: Drug: pegloticase 8 mg i.v. pegloticase 8 mg i.v. every 2 weeks for 24 weeks |